Haemonetics Corporation (HAE)
NYSE: HAE
· Real-Time Price · USD
52.87
0.54 (1.03%)
At close: Aug 15, 2025, 12:01 PM
Haemonetics Cash Flow Statement
Financials in USD. Fiscal
year is
May - April.
| Fiscal Year | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 28, 2025 | Mar 29, 2025 | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Oct 1, 2022 | Jul 2, 2022 | Apr 2, 2022 | Jan 1, 2022 | Oct 2, 2021 | Jul 3, 2021 | Apr 3, 2021 | Dec 26, 2020 | Sep 26, 2020 | Jun 27, 2020 |
Net Income | 34.03M | 57.98M | 37.49M | 33.83M | 38.37M | 20.37M | 31.24M | 24.91M | 41.04M | 29.38M | 32.94M | 33.2M | 19.88M | 9.74M | 23.23M | 14.86M | -4.45M | -11.04M | 31.88M | 48.1M | 10.53M |
Depreciation & Amortization | 28.76M | n/a | 29.02M | 29.22M | 29.14M | 27.64M | 23.53M | 23.01M | 23.03M | 23.85M | 23.57M | 23.44M | 22.45M | 24.81M | 24.37M | 23.53M | 25.03M | 21.91M | 20.77M | 20.88M | 20.72M |
Stock-Based Compensation | 9.31M | n/a | 8.21M | 6.86M | 7.63M | 7.42M | 7.22M | 6.71M | 6.99M | 7.06M | 7.49M | 5.74M | 5.3M | 5.1M | 6.46M | 5.98M | 6.83M | 7.11M | 6.29M | 5.95M | 6.17M |
Other Working Capital | -14.44M | 12.13M | -19.53M | -70.14M | -50.72M | -21.14M | -5.33M | -305K | -8.39M | -11.95M | 4.19M | -1.62M | -3.96M | 16.5M | -5.17M | -2.1M | 3.38M | 9.18M | 785K | 1.04M | -2.68M |
Other Non-Cash Items | 13.32M | 14.21M | 1.99M | 14.93M | -19.98M | 36.06M | 189K | -1.74M | 1.51M | 6.65M | 5.03M | -3.11M | -86K | 2.41M | 1.57M | 1.58M | 15.73M | 26.37M | 1.76M | -31.34M | 2.29M |
Deferred Income Tax | -3.23M | 3.37M | -2.42M | -6.18M | n/a | -11.04M | 4.34M | 14.76M | -1.78M | 4.78M | n/a | n/a | n/a | 3.01M | 1.1M | 1.56M | -5M | -15.91M | -922K | -2.53M | -501K |
Change in Working Capital | -55.48M | 40.99M | -30.54M | -29.84M | -82.58M | 12.59M | -67.06M | 31.47M | -51.7M | 7.89M | -4.62M | 27.78M | -5.54M | 22.98M | 5.71M | -4.05M | -39.82M | -26.89M | 6.51M | -11.91M | -27.39M |
Operating Cash Flow | 17.39M | 116.56M | 43.77M | 48.82M | -27.42M | 64.08M | -540K | 99.12M | 19.09M | 79.61M | 64.42M | 87.04M | 41.99M | 68.05M | 62.43M | 43.46M | -1.68M | 1.55M | 66.29M | 29.16M | 11.81M |
Capital Expenditures | -3.75M | -15.64M | -8.55M | -9.43M | -5.66M | -9.69M | -22.29M | -24.65M | -9.66M | -11.92M | -16.85M | -35.96M | -45.47M | -35.12M | -26.66M | -20.81M | -13.92M | -11.63M | -9.37M | -8.34M | -7.7M |
Cash Acquisitions | 297K | 45.74M | 251K | -22.12M | -149.15M | 2.05M | -243.85M | 519K | 402K | -850K | n/a | 850K | -2.85M | 603K | 10.64M | 292K | -2.5M | -418.2M | -391K | 44.98M | -16.61M |
Purchase of Investments | -18.08M | n/a | n/a | n/a | n/a | -15.55M | n/a | -1M | -6M | 22.81M | -19.81M | -3M | -10.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | -23.73M | n/a | 24.14M | -402K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -11.46M | -12.06M | -8.82M | 8.18M | 15.61M | 10.13M | -2.79M | -24.14M | 402K | -28.05M | 158K | 7.04M | 498K | 603K | 559K | 292K | 568K | 730K | 183K | 496K | 406K |
Investing Cash Flow | -33M | 18.04M | -17.37M | -23.37M | -139.2M | -13.06M | -268.94M | -25.14M | -15.26M | -18.01M | -36.5M | -31.07M | -58.21M | -34.51M | -15.46M | -20.52M | -15.85M | -429.1M | -9.58M | 37.13M | -23.9M |
Debt Repayment | -1.56M | -714.06M | -1.56M | n/a | 450.44M | -63.5M | 106.5M | -3.5M | -1.75M | -1.75M | -51.75M | 47.13M | -4.38M | -4.38M | -4.38M | -4.38M | -4.38M | 491.25M | -154.38M | -64.38M | 145.63M |
Common Stock Repurchased | n/a | -150M | -9.75M | 9.75M | -9.75M | -5.78M | -43K | -4.36M | -1.48M | n/a | n/a | -75M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -4.82M | 12.47M | 2.94M | -74.8M | -121.15M | -2K | 2.93M | -3.67M | 1.15M | 147K | 2.07M | -10K | -19.02M | -4.39M | 2.34M | 1.06M | 2.74M | -58.49M | 4.43M | 57K | 3.33M |
Financial Cash Flow | -2.44M | -151.45M | 1.38M | -74.8M | 333.69M | -63.5M | 109.43M | -7.17M | -598K | -1.6M | -49.68M | -25.69M | -23.39M | -8.77M | -2.04M | -3.31M | -1.63M | 432.76M | -149.94M | -64.32M | 148.95M |
Net Cash Flow | -13.87M | -14.08M | 21.56M | -45.15M | 165.63M | -15.18M | -157.03M | 65.29M | 1.25M | 60.46M | -17.2M | 26.25M | -44.55M | 22.62M | 44.46M | 18.96M | -18.84M | 3.3M | -90.17M | 3.44M | 138.41M |
Free Cash Flow | 13.64M | 100.91M | 35.22M | 39.39M | -33.08M | 54.4M | -22.83M | 74.47M | 9.42M | 67.69M | 47.57M | 51.08M | -3.47M | 32.94M | 35.77M | 22.65M | -15.6M | -10.09M | 56.92M | 20.82M | 4.12M |